List of Studies ( Metabolite:MG 20:1)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003769 | AN006189 | Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease | Brain | Human | Alzheimers disease | University of Melbourne | LC-MS |
| ST003751 | AN006160 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Blood | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006160 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Urine | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003614 | AN005939 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion | Liver | Mouse | University of Bonn | LC-MS | |
| ST003456 | AN005677 | Lipidomics of human serum to support understanding of early metabolic shift in presymptomatic sepsis patients. (Part2 human lipids) | Blood | Human | Sepsis | Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute | LC-MS |
| ST003090 | AN005054 | Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B | Cultured cells | Mouse | Rutgers University | LC-MS | |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Fatty liver disease | University of Bonn | MS(Dir. Inf.) |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Obesity | University of Bonn | MS(Dir. Inf.) |
| ST002334 | AN003810 | Phospholipase D3 impact on the endolysosomal lipidome | Cultured cells | Human | Alzheimers disease | VIB-KU Leuven | LC-MS |
| ST001687 | AN002754 | Non-transformed cells respond to fat by inducing glucose metabolism | Liver | Mouse | VIB-KU Leuven Center for Cancer Biology | LC-MS | |
| ST001477 | AN002453 | Lipidomics dataset of PTEN deletion-induced nerve regeneration mouse model | Eye tissue | Mouse | Eye disease | University of Miami | LC-MS |
| ST001442 | AN002410 | Human Optic Nerve Glaucoma and Control Lipidomes | Eye tissue | Human | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST001381 | AN002301 | Lipid profile Dataset of optogenetics induced optic nerve regeneration | Optic nerve | Mouse | Eye disease | University of Miami | LC-MS |
| ST001269 | AN002109 | Exosomal lipids for classifying early and late stage non-small cell lung cancer | Blood | Human | Cancer | University of Kentucky | MS(Dir. Inf.) |
| ST001121 | AN001846 | Identification of urine metabolites in patients with interstitial cystitis using untargeted metabolomics (part I) | Urine | Human | Interstitial cystitis | University of California, Davis | LC-MS |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST000763 | AN001204 | Untargeted metabolomics and lipidomics of scleroderma PAH discovery cohort | Blood | Human | Scleroderma | University of Michigan | LC-MS |
| ST000665 | AN001017 | Nonalcoholic fatty liver disease (NAFLD) Studies | Cultured cells | Human | Fatty liver disease | University of Michigan | LC-MS |
| ST000148 | AN000235 | A549 13C-labeled Cell Study | Epithelial cells | Human | Cancer | University of Kentucky | LC-MS |
